Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 31384 [2015-13315]
Download as PDF
<![CDATA[
31384
Federal Register / Vol. 80, No. 105 / Tuesday, June 2, 2015 / Notices
Program Expansion for Acute
Respiratory Illness Surveillance
Financed Solely by 2015 Prevention and
Public Health Funds’’, IP–11–
00100501PPHF15.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–13311 Filed 6–1–15; 8:45 am]
[FR Doc. 2015–13315 Filed 6–1–15; 8:45 am]
BILLING CODE 4163–19–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Administration for Children and
Families
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Secretary, HHS, summarizing the results
of completed dose reconstruction
reviews.
The agenda is subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta GA 30333,
Telephone (513)533–6800, Toll Free
1(800) CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[CFDA Number: 93.598]
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), IP–11–00100501PPHF15, PPHF–
2015—Enhanced Surveillance for New
Vaccine Preventable Disease—A
Program Expansion for Acute
Respiratory Illness Surveillance
Financed Solely by 2015 Prevention and
Public Health Funds.
Time and Date: 10:00 a.m.–3:00 p.m.,
June 23, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘PPHF–2015-Enhanced Surveillance for
New Vaccine Preventable Disease—A
VerDate Sep<11>2014
17:26 Jun 01, 2015
Jkt 235001
Announcement of the Award of a
Single-Source Program Expansion
Supplement Grant to the U.S.
Committee for Refugees and
Immigrants in Arlington, VA
Office of Refugee Resettlement,
ACF, HHS.
ACTION: Announcement of the award of
a single-source program expansion
supplement to the U.S. Committee for
Refugees and Immigrants (USCRI) to
support expanded services to foreign
trafficking victims, potential trafficking
victims, and certain family members.
AGENCY:
The Administration for
Children and Families (ACF), Office of
Refugee Resettlement (ORR) announces
the award of a single-source program
expansion supplement grant to U.S.
Committee for Refugees and Immigrants
in Arlington, Virginia for a total of
$1,060,805.
The supplemental funding will ensure
that clients’ essential needs, such as
housing, transportation,
communication, food, and medical care,
will be met. The supplemental funding
will also ensure that USCRI has
sufficient staff for the increased number
of cases.
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
The period of support under
these supplements is June 01, 2015
through September 29, 2015.
FOR FURTHER INFORMATION CONTACT:
Maggie Wynne, Director, Division of
Anti-Trafficking in Persons, Office of
Refugee Resettlement, 901 D Street SW.,
Washington, DC 20024, Telephone (202)
401–4664. Email: maggie.wynne@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: The
National Human Trafficking Victim
Assistance Program (NHTVAP) provides
funding for comprehensive case
management services to victims of
trafficking and certain family members
on a per capita basis. The NHTVAP
grantees help clients gain access to
housing, employability services, mental
health screening and therapy, medical
care, and some legal services. During FY
2015, a grantee, U.S. Committee for
Refugees and Immigrants (USCRI),
served more clients than it had planned
for in its budget for the year. Without
the additional funding, USCRI would
have to make significant cuts in services
to current clients and limit the
enrollment of new clients. Also, without
additional funding USCRI would not
have sufficient programmatic support
for the increase in client enrollments.
With the supplemental funding, USCRI
will be able to ensure that all of the
clients’ essential needs will be met.
DATES:
Statutory Authority: Trafficking Victims
Protection Act of 2000 (TVPA), as amended,
Section 107(b)(1)(B), 22 U.S.C. 7105(b)(1)(B),
authorizes funding for benefits and services
to foreign victims of severe forms of
trafficking in persons in the United States,
potential victims of trafficking seeking HHS
Certification, and certain family members.
Christopher Beach,
Senior Grants Policy Specialist, Office of
Administration.
[FR Doc. 2015–13177 Filed 6–1–15; 8:45 am]
BILLING CODE 4184–47–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0279]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Prescription Drug Marketing Act of
1987; Policies, Requirements, and
Administrative Procedures
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
SUMMARY:
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 80, Number 105 (Tuesday, June 2, 2015)]
[Notices]
[Page 31384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13315]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA), IP-
11-00100501PPHF15, PPHF-2015--Enhanced Surveillance for New Vaccine
Preventable Disease--A Program Expansion for Acute Respiratory Illness
Surveillance Financed Solely by 2015 Prevention and Public Health
Funds.
Time and Date: 10:00 a.m.-3:00 p.m., June 23, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``PPHF-2015-Enhanced Surveillance for New Vaccine Preventable
Disease--A Program Expansion for Acute Respiratory Illness Surveillance
Financed Solely by 2015 Prevention and Public Health Funds'', IP-11-
00100501PPHF15.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-13315 Filed 6-1-15; 8:45 am]
BILLING CODE 4163-18-P
